SUMMARY
The concept of digital twins, widely adopted in industry, is entering healthcare. In this scoping review, we analysed definitions and characteristics of patient digital twins being developed for clinical use. Searching for studies claiming digital twin development/evaluation until August 2023, we identified 86 articles representing 80 unique claimed digital twins, nearly all (98%) in preclinical phases. From the analysis of definitions and characteristics, we propose to define patient digital twin as “a viewable digital replica of a patient, organ, or biological system that contains multidimensional, patient-specific information”. Two main forms were found: simulation digital twins using computational modelling of patient anatomy/physiology to run personalised outcome predictions and therapy evaluations, mostly for one-time assessments; and monitoring digital twins harnessing aggregated patient data for continuous risk/outcome forecasting over time and care optimisation. As patient digital twins rapidly emerge, the proposed definitions and subtypes offer a framework to guide research into realising the potential of these personalised, integrative technologies to advance clinical care.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
